---
author: Harvey Guo
created: 2024-01-18 16:38
modified: 2024-01-18 16:38
aliases:
  - Coronary heart disease
  - Ischemic heart disease
  - Angina
share: true
---

# Epidemiology


---
# Etiology


---
# Pathophysiology


---
# Clinical features


---
# Diagnostics


---
# Treatment
## Approach
- All patients: pharmacotherapy for CAD
	- Start prevention of recurrent CAD, i.e., antiplatelet agents, statins, and management of comorbidities.
	- Start antianginal medication.
## Pharmacotherapy for CAD
### Antianginal drugs
- <span style="background:rgba(240, 200, 0, 0.2)">Goal: reduction of myocardial oxygen demand (MVO2)</span>
- <span style="background:rgba(240, 200, 0, 0.2)">First-line agent: beta blockers</span>
- Second-line agents: CCBs, nitrates, ranolazine
- Third-line agent: Consider ranolazine if beta-blockers, CCBs, and nitrates are ineffective or not tolerated.
![[../../assets/img/Pasted image 20240118164426.png|Pasted image 20240118164426.png]]
### Prevention of recurrence and/or progression
- Antiplatelet agents
- ACEIs or ARBs
- Beta blockers

---
